NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

John Maher

Phase 1 trial: T4 immunotherapy of head and neck cancer

Nasopharynx Oesophagus

Niall Dillon

Gene Regulation and Chromatin

Leukaemia

Stephen N Thibodeau

Prostate Cancer Susceptibility: The ICPCG Study

Prostate

Pathology

Kathryn A Vannatta

Predicting Deficits in Social Competence for Pediatric Brain Tumor Survivors

Brain, nervous system

Pediatric oncology or childhood cancer Radiation Oncology

Mirlinda Kachuri

Comprehensive investigation of telomere length and its genetic determinants in cancer risk and clinical outcomes

Nasopharynx Trachea, bronchus and lung Pancreas Oesophagus

Thomas Kislinger

A Novel Biomarker Discovery Strategy Combining Primary Tumour Xenograft Models and Glyco-Capture of Secreted Proteins

Ovary

Donna Reece

Expediting Patient-Oriented Research in Canada: Development of Myeloma Canada Research Network (MCRN)

Multiple myeloma and immunoproliferative diseases

Linda S Cook

Mitochondrial DNA and Ovarian Cancer Risk and Survival

Ovary

Pathology

Richard Peto

Large randomised trials and meta-analyses of breast cancer treatments

Breast